Rite Aid Price to Sales

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>RA</div>
RAD -- USA Stock  

 Earnings Call  In Two Weeks

Rite Aid price to sales fundamental analysis lookup allows you to check this and other indicators for Rite Aid or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools

Search Price to Sales

 
Refresh
Rite Aid Sales per Share is expected to significantly decrease based on the last few years of reporting. The last year's Sales per Share was at 413.10.

Rite Aid Price to Sales Analysis

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

  Market Capitalization

P/S 
 = 
MV Per Share 
Revenue Per Share 
More About Price to Sales | All Equity Analysis

Current Rite Aid Price to Sales

0.04 

Rite Aid Price to Sales Over Time Pattern

 Rite Aid Price to Sales Ratio 
      Timeline 

About Price to Sales

The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Compare to competition

Rite Aid Price to Sales Related Assessment

  Price to Sales Ratio

Based on latest financial disclosure the price to sales indicator of Rite Aid is roughly 0.04 times. This is 99.81% lower than that of the Healthcare sector, and significantly higher than that of Pharmaceutical Retailers industry, The Price to Sales for all stocks is 99.65% higher than the company.

Did you try this?

Run Theme Ratings Now

   

Theme Ratings

Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Rite Aid Fundamentals

About Rite Aid Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Rite Aid's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rite Aid using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rite Aid based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way. Please read more on our fundamental analysis page.
 2010 2014 2019 2020 (projected)
Receivables949.06 M1.79 B1.29 B1.22 B
Inventories2.99 B1.87 B1.92 B2.57 B
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. Rite Aid Corporation was founded in 1962 and is headquartered in Camp Hill, Pennsylvania. Rite Aid operates under Pharmaceutical Retailers classification in USA and is traded on BATS Exchange. It employs 29840 people.


 
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page